Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
amisulpride, Quantity: 100 mg
Southern Cross Pharma Pty Ltd
Amisulpride
Tablet, uncoated
Excipient Ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate type A; hypromellose; microcrystalline cellulose
Oral
30, 90, 60
(S4) Prescription Only Medicine
Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
Visual Identification: White, round, flat tablets with diameter 9.5 mm, embossed MC on one side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-01-29